Guest Editors:
Jianhai Jiang, PhD, Fudan University, China
Charles K. Kaufman, MD, PhD, Washington University School of Medicine, USA
Hernando Lopez-Bertoni, PhD, Johns Hopkins School of Medicine, USA
Ander Matheu, PhD, Biodonostia Health Research Institute (IIS Biodonostia) San Sebastian, Spain
Submission Status: Open | Submission Deadline: 13 November 2024
BMC Biology is calling for submissions to our Collection on Stem cells and cancer. This Collection aims to explore the intricate relationship between stem-cell and cancer biology.
In particular, we welcome studies providing new insights on the characterization and regulation of cancer stem cells, the role of stem and progenitor cells of the niche in the propagation of the tumor, and the role of reprogramming in this context, as well as potential therapeutic strategies based on reprogramming or targeting of various stem and progenitor cells. Moreover, studies describing the use of induced pluripotent stem cells for cancer modeling and as a drug discovery platform will also be considered, as well as studies on the use of stem cells homing to deliver targeted therapy to tumors.